Sitemap
- Home
- About us
- Products
- Careers
-
Investors
- About GSK
- New GSK
- A new consumer healthcare company
- Consumer Healthcare Capital Markets Day
- Quarterly results
- Shareholder information
- Share price analysis
- Speeches & presentations
- Analyst consensus
- Financial calendar
- Corporate reporting
- Debt investors
- Stock exchange announcements
- Investors contact details
- Corporate actions
- Media
- Research and development
- Responsibility
- Contact us
-
Behind the science
- Combining genetics and tech to double success rates for patients
- Outstanding People: Meet Marilyn
- Getting ahead of infectious diseases with advanced technology
- Outstanding People: Meet Stefan
- Advancing the Next Generation of Immuno-Oncology
- Inside the vaccine factory of the future
- mRNA (Messenger ribonucleic acid): Disrupting the field of vaccinology
- Combatting COVID-19: How do we tackle emerging variants?
- Following the science of oxygen to discover solutions for anaemia
- 40 years and counting: the fight against HIV
- Augmented reality and the changing face of consumer healthcare
- Our focus on developing the next generation of antibiotics
- Delivering potentially transformational medicines through R&D innovation in Oncology
- Outstanding People: Meet Sumitra
- How do you test medicines in the real world?
- The vaccines of tomorrow
- Inclusive design: making our differences invisible
- Unravelling the mysteries of the human genome with functional genomics
- Outstanding People: Meet Sanjay
- Using vaccine science to get ahead of antimicrobial resistance
- Looking deeper into lupus
- Immuno-Oncology: Integrating innovation into standard of care practice
- Asthma management: it’s time to get personal
- TB: uniting scientists to tackle one of the world’s biggest killers
- Making the switch: how we’re improving access to proven medicines
- The lung microbiome and the future management of respiratory disease
- Revealing the beautiful complexity of the immune system
- Why collaboration is essential to achieving new breakthroughs in vaccines
- Tackling tomorrow’s health challenges today
- From eucalyptus toothpaste to a brew for the flu: tailoring products to different tastes
- STEM – inspiring tomorrow’s science and engineering superstars
- We need more women in science to create the inclusive technologies of the future
- Inside the Open Lab
- How adjuvants boost our immune response
- Outstanding People: Meet Hangfei
- Outstanding People: Meet Graeme
- Outstanding People: Meet Kevin
- Outstanding People: Meet Umesh
- Outstanding People: Meet Erin
- 1.4 Million Reasons to Transform The Future of Women’s Cancer
- Making the invisible, visible - to better understand tooth sensitivity
- Could tiny bubbles released from bacteria cells pave the way for new vaccine technology?
- AI and ML power better predictions for patient impact
- Antibiotic resistance: now’s the time to prevent the next pandemic
- Fresh insights could finally help us tackle RSV
- Computational Biology: Setting the stage for future wins and new medicines
- Shingles is here: 1 in 3 adults will develop shingles in their lifetime
- How we’re getting ahead of an incurable blood cancer
- Targeting treatable traits in asthma and other respiratory conditions
- Outstanding People: Meet Giovanna
- What if Remission were the Target of Lupus Care?
- Outstanding People: Meet Jeremy
- Outstanding People: Meet Shihyun
- Outstanding People: Meet Katie
- Tech for T-cells: single cell RNA-seq measures shifts in immune cells to pinpoint causes of disease
- Unlocking the power of the immune system to get ahead of hepatitis B
- Terms of use
- Accessibility
- Cookie policy
- GSK employees
- Privacy Notice
- GSK Instagram
- American Society of Nephrology (ASN) Kidney Week 2021
- GSK 2021 Oncology Medical Congress Conference
- Additional Information and Where to Find It
- GSK at Oncology Medical Congresses 2022